| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA1644519
Max Phase: Preclinical
Molecular Formula: C11H15BrFN3
Molecular Weight: 207.25
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Br.NCC[C@H]1CNC(c2ccccc2F)=N1
Standard InChI: InChI=1S/C11H14FN3.BrH/c12-10-4-2-1-3-9(10)11-14-7-8(15-11)5-6-13;/h1-4,8H,5-7,13H2,(H,14,15);1H/t8-;/m0./s1
Standard InChI Key: UOBWBCOLYXBTNQ-QRPNPIFTSA-N
Associated Targets(non-human)
Nischarin 241 Activities
Adrenergic receptor alpha-2 3313 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 207.25 | Molecular Weight (Monoisotopic): 207.1172 | AlogP: 0.89 | #Rotatable Bonds: 3 |
| Polar Surface Area: 50.41 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 9.54 | CX LogP: 0.69 | CX LogD: -1.55 |
| Aromatic Rings: 1 | Heavy Atoms: 15 | QED Weighted: 0.77 | Np Likeness Score: -0.08 |
References
| 1. Treder AP, Andruszkiewicz R, Zgoda W, Walkowiak A, Ford C, Hudson AL.. (2011) New imidazoline/α(2)-adrenoceptors affecting compounds-4(5)-(2-aminoethyl)imidazoline (dihydrohistamine) derivatives. Synthesis and receptor affinity studies., 19 (1): [PMID:21159515] [10.1016/j.bmc.2010.11.039] |
Source
Source(1):